SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-028190
Filing Date
2024-03-07
Accepted
2024-03-07 17:46:49
Documents
1
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 14911
  Complete submission text file 0000950170-24-028190.txt   16534
Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
O'Connor Daniel J. (Reporting) CIK: 0001376847 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-56600 | Film No.: 24731556

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Issuer) CIK: 0001990550 (see all company filings)

IRS No.: 932892120 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)